Alya Kahn McGinlay

Title: Alya Kahn McGinlay: Innovator in Pharmaceutical Formulations

Introduction

Alya Kahn McGinlay is a notable inventor based in Belmont, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. Her work focuses on improving the bioavailability of medications, which is crucial for effective treatment.

Latest Patents

Alya holds 1 patent for her invention titled "Immediate release formulations and dosage forms of gamma-hydroxybutyrate." This patent presents a solid immediate release dosage form adapted for oral administration of gamma-hydroxybutyrate (GHB). The formulation includes a relatively high weight-percentage of GHB, achieving bioavailability similar to that of liquid GHB dosage forms. This advancement has the potential to enhance patient compliance and treatment outcomes.

Career Highlights

Alya is currently employed at Jazz Pharmaceuticals, Inc., where she continues to innovate in the pharmaceutical sector. Her expertise in formulation science has positioned her as a valuable asset to her team and the company.

Collaborations

Alya has collaborated with several talented professionals, including Andrea Marie Rourke and Maura Patricia Murphy. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Alya Kahn McGinlay's contributions to pharmaceutical formulations exemplify her commitment to innovation and improving patient care. Her work continues to influence the industry positively, paving the way for future advancements in medication delivery systems.